Search Results - "Vántus, Viola Bagóné"

  • Showing 1 - 8 results of 8
Refine Results
  1. 1
  2. 2

    Highly Selective MIF Ketonase Inhibitor KRP-6 Diminishes M1 Macrophage Polarization and Metabolic Reprogramming by Vámos, Eszter, Kálmán, Nikoletta, Sturm, Eva Maria, Nayak, Barsha Baisakhi, Teppan, Julia, Vántus, Viola Bagóné, Kovács, Dominika, Makszin, Lilla, Loránd, Tamás, Gallyas, Ferenc, Radnai, Balázs

    Published in Antioxidants (22-09-2023)
    “…Macrophage polarization is highly involved in autoimmunity. M1 polarized macrophages drive inflammation and undergo metabolic reprogramming, involving…”
    Get full text
    Journal Article
  3. 3

    Distinct Uptake Routes Participate in Silver Nanoparticle Engulfment by Earthworm and Human Immune Cells by Kokhanyuk, Bohdana, Vántus, Viola Bagóné, Radnai, Balázs, Vámos, Eszter, Kajner, Gyula, Galbács, Gábor, Telek, Elek, Mészáros, Mária, Deli, Mária A., Németh, Péter, Engelmann, Péter

    Published in Nanomaterials (Basel, Switzerland) (01-08-2022)
    “…The consequences of engineered silver nanoparticle (AgNP) exposure and cellular interaction with the immune system are poorly understood. The immunocytes of…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6

    Effect of Oxaliplatin, Olaparib and LY294002 in Combination on Triple-Negative Breast Cancer Cells by Andreidesz, Kitti, Koszegi, Balazs, Kovacs, Dominika, Bagone Vantus, Viola, Gallyas, Ferenc, Kovacs, Krisztina

    “…Triple-negative breast cancer (TNBC) has a poor prognosis as the therapy has several limitations, most importantly, treatment resistance. In this study we…”
    Get full text
    Journal Article
  7. 7

    Cytostatic Effect of a Novel Mitochondria-Targeted Pyrroline Nitroxide in Human Breast Cancer Lines by Andreidesz, Kitti, Szabo, Aliz, Kovacs, Dominika, Koszegi, Balazs, Bagone Vantus, Viola, Vamos, Eszter, Isbera, Mostafa, Kalai, Tamas, Bognar, Zita, Kovacs, Krisztina, Gallyas, Ferenc

    “…Mitochondria have emerged as a prospective target to overcome drug resistance that limits triple-negative breast cancer therapy. A novel mitochondria-targeted…”
    Get full text
    Journal Article
  8. 8